<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04250090</url>
  </required_header>
  <id_info>
    <org_study_id>ECKIRB1050505</org_study_id>
    <nct_id>NCT04250090</nct_id>
  </id_info>
  <brief_title>Post-Marketing Follow-Up of Long-term Type Ureteral Stent Set</brief_title>
  <official_title>Post-Marketing Follow-Up of Long-term Type Ureteral Stent Set</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>En Chu Kong Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>En Chu Kong Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ureteral stents have been widely used in many urological operations. Although there are
      several reports regarding the effectiveness of long-term ureteral stents for malignancy
      ureteral obstruction, ureteral stricture and urolithiasis, the experience is limited about
      the long-term ureteral stents made by Taiwan. The investigators have to propose the 5-year
      post-market survey report. Though this observation study, The investigators can further
      understand the clinical safety and effectiveness of placing ureteral stents
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ureteral stents have been widely used in many urological operations. The main purposes of
      placing ureteral stents include improvement of ureteral obstruction, protecting renal
      function and drainage of infection. Although there are several reports regarding the
      effectiveness of long-term ureteral stents for malignancy ureteral obstruction, ureteral
      stricture and urolithiasis, the experience is limited about the long-term ureteral stents
      made by Taiwan. Thus, The investigators will conduct this post-marketing survey to observe
      and investigate the changes of ureteral stents, e.g. hydronephrosis, infection and stone
      formation. Now this product has been approved by European Medical Device Administration. The
      investigators have to propose the 5-year post-market survey report. Though this observation
      study, The investigators can further understand the clinical safety and effectiveness of
      placing ureteral stents
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 9, 2019</start_date>
  <completion_date type="Anticipated">October 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Hydronephrosis</measure>
    <time_frame>5 years</time_frame>
    <description>no hydronephrosis, mild hydronephrosis, moderate hydronephrosis, severe hydronephrosis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Renal function</measure>
    <time_frame>5 years</time_frame>
    <description>serum BUN level</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Renal function</measure>
    <time_frame>5 years</time_frame>
    <description>serum Creatine level</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Days of stent placement</measure>
    <time_frame>5 years</time_frame>
    <description>Mean days of stent placement</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Ureter Stricture</condition>
  <condition>Hydronephrosis</condition>
  <arm_group>
    <arm_group_label>Long-term type ureteral stent set</arm_group_label>
    <description>Patients with Long-term type ureteral stent set due to ureteral stricture.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The most recent patients who actually used the &quot; Bioteq&quot; Ureteral Stent Set (Long-Term
        Type) are included, and a non-grouping method is adopted
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients who used &quot; Bioteq&quot; Ureteral Stent Set (Long-Term Type) in their treatments.

          2. Patients with complete basic parameters.

        Exclusion Criteria:

          1. Patients with any of the following conditions are excluded from this clinical study:

             Patients with incomplete basic parameters.

          2. The minorities, children and special populations
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chung Cheng Wang, MD. Ph. D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Deputy Superintendent of Department of Education and Research</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chung Cheng Wang, MD. Ph. D</last_name>
    <phone>886-226723456</phone>
    <phone_ext>6620</phone_ext>
    <email>ericwcc@ms27.hinet.net</email>
  </overall_contact>
  <location>
    <facility>
      <name>En Chu Kong Hospital</name>
      <address>
        <city>New Taipei City</city>
        <state>Sanxia Dist.</state>
        <zip>23702</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chung Cheng Wang, Ph. D</last_name>
      <phone>886-226723456</phone>
      <phone_ext>6620</phone_ext>
      <email>ericwcc@ms27.hinet.net</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <results_reference>
    <citation>Liatsikos EN, Kagadis GC, Barbalias GA, Siablis D. Ureteral metal stents: a tale or a tool? J Endourol. 2005 Oct;19(8):934-9. Review.</citation>
    <PMID>16253054</PMID>
  </results_reference>
  <results_reference>
    <citation>Zeljko M, Markovic B, Mladenovic A, Mijailović M, Lukić S. Balloon dilatation and insertion of temporary coated stents using a retrograde approach in patients with irreversible strictures of the distal ureter. Jpn J Radiol. 2010 Nov;28(9):695-9. doi: 10.1007/s11604-010-0485-2. Epub 2010 Nov 27.</citation>
    <PMID>21113756</PMID>
  </results_reference>
  <results_reference>
    <citation>Bach T, Geavlete B, Herrmann TW, Gross AJ. Retrograde blind endoureterotomy for subtotal ureteral strictures: a new technique. J Endourol. 2008 Nov;22(11):2565-70. doi: 10.1089/end.2008.0173.</citation>
    <PMID>19046096</PMID>
  </results_reference>
  <results_reference>
    <citation>Aytekin C, Boyvat F, Harman A, Ozyer U, Colak T, Haberal M. Percutaneous therapy of ureteral obstructions and leak after renal transplantation: long-term results. Cardiovasc Intervent Radiol. 2007 Nov-Dec;30(6):1178-84. Epub 2007 May 17.</citation>
    <PMID>17508243</PMID>
  </results_reference>
  <results_reference>
    <citation>Kim BM, Park SI. Placement of double-J ureteric stent using the pull-through technique in patients with tight ureteric stenosis. Abdom Imaging. 2008 Mar-Apr;33(2):237-40.</citation>
    <PMID>17440767</PMID>
  </results_reference>
  <results_reference>
    <citation>Juaneda B, Alcaraz A, Bujons A, Guirado L, Díaz JM, Martí J, de la Torre P, Sabaté S, Villavicencio H. Endourological management is better in early-onset ureteral stenosis in kidney transplantation. Transplant Proc. 2005 Nov;37(9):3825-7.</citation>
    <PMID>16386552</PMID>
  </results_reference>
  <results_reference>
    <citation>Egilmez T, Guvel S, Kilinc F, Yaycioglu O, Ozkardes H. Management of complete ureteral obstructions with a transluminal puncture technique. Int Braz J Urol. 2005 May-Jun;31(3):264-8.</citation>
    <PMID>15992432</PMID>
  </results_reference>
  <results_reference>
    <citation>Uthappa MC, Cowan NC. Retrograde or antegrade double-pigtail stent placement for malignant ureteric obstruction? Clin Radiol. 2005 May;60(5):608-12.</citation>
    <PMID>15851050</PMID>
  </results_reference>
  <results_reference>
    <citation>Unsal A, Cimentepe E, Balbay MD. Routine ureteral dilatation is not necessary for ureteroscopy. Int Urol Nephrol. 2004;36(4):503-6.</citation>
    <PMID>15787325</PMID>
  </results_reference>
  <results_reference>
    <citation>Mattei A, Danuser H. [Stents in urology]. Ther Umsch. 2003 Apr;60(4):233-7. German.</citation>
    <PMID>12731434</PMID>
  </results_reference>
  <results_reference>
    <citation>Barbalias GA, Liatsikos EN, Kalogeropoulou C, Karnabatidis D, Zabakis P, Athanasopoulos A, Perimenis P, Siablis D. Externally coated ureteral metallic stents: an unfavorable clinical experience. Eur Urol. 2002 Sep;42(3):276-80.</citation>
    <PMID>12234513</PMID>
  </results_reference>
  <results_reference>
    <citation>Hibi H, Kato K, Mitsui K, Taki T, Yamada Y, Honda N, Fukatsu H. Endoscopic ureteral incision using the holmium:YAG laser. Int J Urol. 2001 Dec;8(12):657-61.</citation>
    <PMID>11851764</PMID>
  </results_reference>
  <results_reference>
    <citation>Micali S, De Carli P, Miano R, O'Sullivan D, Lamanna L, Micali F. Double-J ureteral stents: an alternative to external urinary stents in orthotopic bladder substitution. Eur Urol. 2001 May;39(5):575-9.</citation>
    <PMID>11464040</PMID>
  </results_reference>
  <results_reference>
    <citation>Lin DW, Bush WH, Mayo ME. Endourological treatment of ureteroenteric strictures: efficacy of Acucise endoureterotomy. J Urol. 1999 Sep;162(3 Pt 1):696-8. Review.</citation>
    <PMID>10458345</PMID>
  </results_reference>
  <results_reference>
    <citation>Puppo P, Ricciotti G, Bozzo W, Introini C. Primary endoscopic treatment of ureteric calculi. A review of 378 cases. Eur Urol. 1999;36(1):48-52.</citation>
    <PMID>10364655</PMID>
  </results_reference>
  <results_reference>
    <citation>Ravery V, de la Taille A, Hoffmann P, Moulinier F, Hermieu JF, Delmas V, Boccon-Gibod L. Balloon catheter dilatation in the treatment of ureteral and ureteroenteric stricture. J Endourol. 1998 Aug;12(4):335-40.</citation>
    <PMID>9726399</PMID>
  </results_reference>
  <results_reference>
    <citation>Zimskind PD, Fetter TR, Wilkerson JL. Clinical use of long-term indwelling silicone rubber ureteral splints inserted cystoscopically. J Urol. 1967 May;97(5):840-4.</citation>
    <PMID>6025928</PMID>
  </results_reference>
  <results_reference>
    <citation>Richter S, Ringel A, Shalev M, Nissenkorn I. The indwelling ureteric stent: a 'friendly' procedure with unfriendly high morbidity. BJU Int. 2000 Mar;85(4):408-11.</citation>
    <PMID>10691815</PMID>
  </results_reference>
  <results_reference>
    <citation>Pocock RD, Stower MJ, Ferro MA, Smith PJ, Gingell JC. Double J stents. A review of 100 patients. Br J Urol. 1986 Dec;58(6):629-33.</citation>
    <PMID>3801820</PMID>
  </results_reference>
  <results_reference>
    <citation>Saltzman B. Ureteral stents. Indications, variations, and complications. Urol Clin North Am. 1988 Aug;15(3):481-91. Review.</citation>
    <PMID>3043868</PMID>
  </results_reference>
  <results_reference>
    <citation>Ahallal Y, Khallouk A, El Fassi MJ, Farih MH. Risk factor analysis and management of ureteral double-j stent complications. Rev Urol. 2010 Spring;12(2-3):e147-51.</citation>
    <PMID>20811552</PMID>
  </results_reference>
  <results_reference>
    <citation>Lam JS, Gupta M. Tips and tricks for the management of retained ureteral stents. J Endourol. 2002 Dec;16(10):733-41.</citation>
    <PMID>12542876</PMID>
  </results_reference>
  <results_reference>
    <citation>Borboroglu PG, Kane CJ. Current management of severely encrusted ureteral stents with a large associated stone burden. J Urol. 2000 Sep;164(3 Pt 1):648-50.</citation>
    <PMID>10953117</PMID>
  </results_reference>
  <results_reference>
    <citation>Mohan-Pillai K, Keeley FX Jr, Moussa SA, Smith G, Tolley DA. Endourological management of severely encrusted ureteral stents. J Endourol. 1999 Jun;13(5):377-9.</citation>
    <PMID>10446801</PMID>
  </results_reference>
  <results_reference>
    <citation>Schulze KA, Wettlaufer JN, Oldani G. Encrustation and stone formation: complication of indwelling ureteral stents. Urology. 1985 Jun;25(6):616-9.</citation>
    <PMID>4012953</PMID>
  </results_reference>
  <results_reference>
    <citation>el-Faqih SR, Shamsuddin AB, Chakrabarti A, Atassi R, Kardar AH, Osman MK, Husain I. Polyurethane internal ureteral stents in treatment of stone patients: morbidity related to indwelling times. J Urol. 1991 Dec;146(6):1487-91.</citation>
    <PMID>1942324</PMID>
  </results_reference>
  <results_reference>
    <citation>Somers WJ. Management of forgotten or retained indwelling ureteral stents. Urology. 1996 Mar;47(3):431-5.</citation>
    <PMID>8633417</PMID>
  </results_reference>
  <results_reference>
    <citation>Singh I, Gupta NP, Hemal AK, Aron M, Seth A, Dogra PN. Severely encrusted polyurethane ureteral stents: management and analysis of potential risk factors. Urology. 2001 Oct;58(4):526-31.</citation>
    <PMID>11597531</PMID>
  </results_reference>
  <results_reference>
    <citation>Kilciler M, Erdemir F, Bedir S, Coban H, Erten K, Guven O, Topac H. Spontaneous ureteral stent fragmentation: a case report and review of the literature. Kaohsiung J Med Sci. 2006 Jul;22(7):363-6.</citation>
    <PMID>16849106</PMID>
  </results_reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>January 17, 2020</study_first_submitted>
  <study_first_submitted_qc>January 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 31, 2020</study_first_posted>
  <last_update_submitted>February 7, 2020</last_update_submitted>
  <last_update_submitted_qc>February 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>En Chu Kong Hospital</investigator_affiliation>
    <investigator_full_name>ChungChengWang</investigator_full_name>
    <investigator_title>Chief of urology</investigator_title>
  </responsible_party>
  <keyword>Ureter Stricture</keyword>
  <keyword>Hydronephrosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydronephrosis</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

